L. Balacescu

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
L Balacescu, Loredana Balacescu, Loredana Bălăcescu
Publication record
81 papers · 1,080 citations · H-index 18

PAPERS

Exploring the mechanisms of early acquired resistance to doxorubicin in melanoma spheroids
20250 citationsauthor #3
Gene Expression Profiles Modulated by Lipophilic Sea Buckthorn ( Hippophae rhamnoides L.) Extract in BT‐549 Triple‐Negative Breast Cancer Cells
20250 citationsauthor #2
Curcumin reverses irinotecan-acquired resistance in DLD1 colorectal cancer cells: Insights from whole transcriptomic data.
20251 citationsauthor #3
The transcriptional landscape of cancer stem-like cell functionality in breast cancer
20245 citationsauthor #11
Gene expression-phenotype association study reveals the dual role of TNF-α/TNFR1 signaling axis in confined breast cancer cell migration.
20240 citationsauthor #2
Molecular Subtypes, microRNAs and Immunotherapy Response in Metastatic Colorectal Cancer
202410 citationsauthor #4
Real-World Data on Second-Line Therapy with Ramucirumab for Metastatic Gastric Cancer: A Two-Center Study on Romanian Population
20231 citationsauthor #2
Maize cytolines as models to study the impact of different cytoplasms on gene expression under heat stress conditions
20231 citationsauthor #2
The Bioactive Properties of Carotenoids from Lipophilic Sea buckthorn Extract (Hippophae rhamnoides L.) in Breast Cancer Cell Lines
202315 citationsauthor #5
Baseline Expression of Exosomal miR-92a-3p and miR-221-3p Could Predict the Response to First-Line Chemotherapy and Survival in Metastatic Colorectal Cancer
202313 citationsauthor #2
The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy
20229 citationsauthor #11
Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients
202225 citationsauthor #2
Breast Cancer-Delivered Exosomal miRNA as Liquid Biopsy Biomarkers for Metastasis Prediction: A Focus on Translational Research with Clinical Applicability
202229 citationsauthor #6
Long Noncoding RNA NEAT1 as a Potential Candidate Biomarker for Prostate Cancer
202114 citationsauthor #4
Predictive Efficacy of MiR-125b-5p, MiR-17-5p, and MiR-185-5p in Liver Metastasis and Chemotherapy Response Among Advanced Stage Colorectal Cancer Patients
202119 citationsauthor #2
Decrease of oncological patients' hospital visits during Covid-19 pandemic; the experience of a tertiary Romanian centre.
20215 citationsauthor #6
Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysis
20212 citationsauthor #20
Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors—A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia
20213 citationsauthor #15
Critical Aspects Concerning the Development of a Pooling Approach for SARS-CoV-2 Diagnosis Using Large-Scale PCR Testing
20216 citationsauthor #3
Doubling the Dose of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer–the Experience of a Tertiary Cancer Center
20215 citationsauthor #17
Treatment beyond progression in metastatic colorectal cancer: to double or not to double the dose of bevacizumab?
20202 citationsauthor #18
A new desensitization protocol, overcoming hypersensitivity reactions to chemotherapy.
20200 citationsauthor #12
Current and New Predictors for Treatment Response in Metastatic Colorectal Cancer. The Role of Circulating miRNAs as Biomarkers
202013 citationsauthor #2
MicroRNAs mediate liver transcriptome changes upon soy diet intervention in mice
20195 citationsauthor #2
Biomarker Potential of Plasma MicroRNA-150-5p in Prostate Cancer
201930 citationsauthor #8
How reliable and useful are angiogenesis blood mediators for prostate cancer diagnosis?
20190 citationsauthor #3
Interleukin-6 correlated with neutrophil-to-lymphocyte ratio in pancreatic cancer.
20193 citationsauthor #6
Interleukin 8 as predictive factor for response to chemotherapy in colorectal cancer patients
201911 citationsauthor #3
Gastric cancer: adjuvant chemotherapy versus chemoradiation. A clinical point of view.
201921 citationsauthor #7
Proinflammatory cytokines as predictive factors for response to chemotherapy or mental disorders present in colorectal cancer patients.
20190 citationsauthor #3
MiRNA-Based Therapeutics in Oncology, Realities, and Challenges
201820 citationsauthor #4
The Impact of miRNA in Colorectal Cancer Progression and Its Liver Metastases
2018135 citationsauthor #8
Psychological disorders in relation to pain syndrome in patients with colorectal cancer
20180 citationsauthor #4
Biomarkers for the early detection of relapses in metastatic colorectal cancers.
20178 citationsauthor #7
The Role of PDGFs and PDGFRs in Colorectal Cancer
2017113 citationsauthor #2
Urinary microRNAs for prostate cancer diagnosis, prognosis, and treatment response: are we there yet?
201720 citationsauthor #5
The Role of miRNAs in Diagnosis, Prognosis and Treatment Prediction in Cervical Cancer
20179 citationsauthor #1
Blood Genome-Wide Transcriptional Profiles of HER2 Negative Breast Cancers Patients
20169 citationsauthor #2
Tumor markers used in monitoring the tumor recurrence in patients with colorectal cancer
20164 citationsauthor #3
Expression of Tissue Markers in Malignant and Benign Melanocytic Proliferations – a Comparative Study
20160 citationsauthor #3
Maize Cytolines Unmask Key Nuclear Genes That Are under the Control of Retrograde Signaling Pathways in Plants
201618 citationsauthor #4
Introduction Is there a correlation between peripheral blood expression of angiogenic transcriptional factors / receptors and colorectal cancer ?
20150 citationsauthor #2
The Impact of the Preprocessing Methods in Downstream Analysis of Agilent Microarray Data
20151 citationsauthor #1
Can we change our microbiome to prevent colorectal cancer development?
201523 citationsauthor #3
Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes.
201559 citationsauthor #3
Baseline blood immunological profiling differentiates between Her2–breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response
20157 citationsauthor #3
Regulation of stem cells-related signaling pathways in response to doxorubicin treatment in Hs578T triple-negative breast cancer cells
201512 citationsauthor #3
MicroRNAs as non-invasive screening biomarkers of colorectal cancer
201512 citationsauthor #3
Is there a correlation between peripheral blood expression of angiogenic transcriptional factors/receptors and colorectal cancer?
201512 citationsauthor #2
Exposure to zearalenone mycotoxin alters in vitro porcine intestinal epithelial cells by differential gene expression.
201565 citationsauthor #6
Gene Expression of Indoleamine 2,3 Dioxygenase 1, Insulin-Growth Factor 1 and Red/IK Cytokine in Alopecia Areata
20140 citationsauthor #3
PDGF beta targeting in cervical cancer cells suggest a fine-tuning of compensatory signalling pathways to sustain tumourigenic stimulation
20149 citationsauthor #3
Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure
20140 citationsauthor #2
Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure
201451 citationsauthor #2
Differential Peripheral Blood Gene Expression Profile Based on Her2 Expression on Primary Tumors of Breast Cancer Patients
201410 citationsauthor #3
Correction: Differential Peripheral Blood Gene Expression Profile Based on Her2 Expression on Primary Tumors of Breast Cancer Patients
20140 citationsauthor #1
An alternative and sensitive method based on LCM and Q-PCR for HER2 testing in breast cancer
20144 citationsauthor #3
The significance of PDGF expression in serum of colorectal carcinoma patients--correlation with Duke's classification. Can PDGF become a potential biomarker?
201312 citationsauthor #3
Oxaliplatin induces different cellular and molecular chemoresistance patterns in colorectal cancer cell lines of identical origins
201335 citationsauthor #6
Soluble CD163 serum levels are elevated and correlated with IL-12 and CXCL10 in patients with long-standing rheumatoid arthritis
201323 citationsauthor #4
Abstract C6: Molecular and cellular signaling of PDGFB in cervical cancer cells.
20130 citationsauthor #4
Novel cellular and molecular approaches to stratification and treatment of colorectal cancer.
20127 citationsauthor #7
Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells
201247 citationsauthor #4
P1.02 Predicting Treatment Response Based on Gene Expression Profiling on Primary Biopsy in Cervical Cancer
20120 citationsauthor #2
247 Alterations of Cellular and Molecular Patterns in Oxaliplatin Resistant Colorectal Adenocarcinoma Cell Lines
20120 citationsauthor #6
Prognostic significance of the serum level of different growth factors and their correlation with estrogen receptors in patients with locally advanced breast cancer
20111 citationsauthor #5
Identifying molecular features for prostate cancer with Gleason 7 based on microarray gene expression profiles.
20117 citationsauthor #1
Risk Factors in a Sample of Patients with Advanced Cervical Cancer
20118 citationsauthor #6
Molecular angiogenesis profile as a tool to discriminate chronic pancreatitis (CP) from pancreatic cancer (PC).
20116 citationsauthor #4
Intracellular Signaling Pathway Genes Involved in Pancreatic Adenocarcinoma: A Microarray Tissue Analysis
20110 citationsauthor #4
The clinical implications of platelet derived growth factor B, vascular endothelial growth factor and basic fibroblast growth factor in colorectal cancer.
201114 citationsauthor #5
Risk Profile in a Sample of Patients with Breast Cancer from the Public Health Perspective
20102 citationsauthor #9
Mining knowledge and data to discover intelligent molecular biomarkers: Prostate cancer i-Biomarkers
20108 citationsauthor #4
Developing nanotechnology based cancer therapeutics : RNA interference as a powerfull tool in gene silencing for p 53
20100 citationsauthor #4
INDIVIDUAL AND COMBINED CYTOTOXIC EFFECTS OF THE MAJOR FOUR AFLATOXINS IN DIFFERENT IN VITRO STABILIZED SYSTEMS
201014 citationsauthor #4
Contents Vol. 2, 2008
20090 citationsauthor #3
Angiogenesis Serum Protein Quantification for Prostate Pathology
20098 citationsauthor #3
Evaluation of tumor angiogenesis through VEGF modulation in ovarian cancer in vivo using RNA interference
20091 citationsauthor #5
Clinical and pharmacokinetics study of oxaliplatin in colon cancer patients.
200932 citationsauthor #9
p53 gene therapy using RNA interference.
20098 citationsauthor #5
Subject Index Vol. 2, 2008
20090 citationsauthor #3

TIMELINE

2009 49 citations

2010 24 citations

2011 36 citations

2012 54 citations

2013 70 citations

2014 74 citations

2015 191 citations

2016 31 citations

2017 150 citations

2018 155 citations

2019 70 citations

2020 15 citations

2021 54 citations

2022 63 citations

2023 30 citations

2024 15 citations

2025 1 citations

COAUTHOR MAP

CONCEPT FOOTPRINT